AM vs BP

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong profitability metrics like an 81.29% gross margin and 22.52% ROE, the company faces significant risks including a high 91.84% dividend payout ratio, elevated debt/equity of 1.46, and deteriorating earnings momentum. Insider selling, weak recent earnings beats (1 of last 4), and a technical trend score of 10/100 further signal caution. Although the stock trades near analyst target ($18.75 vs $18.93), it is overvalued relative to the Graham Number of $9.77, suggesting limited margin of safety for defensive investors.

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.